As the ligand of PD-1, PD-L1 is highly expressed on various types of cancers, including NSCLC, and it plays an important roles in maintaining an immunosuppressive microenvironment to protect tumor cells from destruction by the immune system [7]. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.